Immediate Impact
2 from Science/Nature 52 hit
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Hit
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Hit
Works of Etsuko Yokota being referenced
Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells
2021
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Etsuko Yokota | 165 | 86 | 71 | 44 | 31 | 23 | 300 | |
| Kálmán Szenthe | 105 0.6× | 45 0.5× | 104 1.5× | 31 0.7× | 56 1.8× | 27 | 324 | |
| Samaresh Chaudhuri | 96 0.6× | 40 0.5× | 46 0.6× | 39 0.9× | 11 0.4× | 21 | 338 | |
| Yukie Matsumoto | 133 0.8× | 34 0.4× | 91 1.3× | 20 0.5× | 10 0.3× | 14 | 343 | |
| Chureerat Phokaew | 280 1.7× | 60 0.7× | 20 0.3× | 58 1.3× | 40 1.3× | 21 | 362 | |
| Ulrike Beyer | 198 1.2× | 65 0.8× | 69 1.0× | 51 1.2× | 21 0.7× | 27 | 354 | |
| Yukiko Ishibashi | 113 0.7× | 17 0.2× | 58 0.8× | 51 1.2× | 29 0.9× | 29 | 329 | |
| Jinqiu Fu | 173 1.0× | 50 0.6× | 24 0.3× | 38 0.9× | 10 0.3× | 25 | 320 | |
| Lijuan Zhu | 233 1.4× | 48 0.6× | 50 0.7× | 129 2.9× | 17 0.5× | 33 | 351 | |
| Jae Ho Lee | 186 1.1× | 42 0.5× | 98 1.4× | 71 1.6× | 21 0.7× | 20 | 342 | |
| Yuko Kusakabe | 163 1.0× | 73 0.8× | 60 0.8× | 42 1.0× | 38 1.2× | 31 | 276 |
All Works
Loading papers...